26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

acute lymphoblastic leukemia (ALL) 13 acute lymphoblastic leukemia (ALL)<br />

0 SS 1024<br />

CD10 1000<br />

0.1<br />

CD5 PC5 1000<br />

0.1<br />

C<br />

0.1<br />

0.1<br />

B<br />

CD45 ECD<br />

1000<br />

inflammation. Bradykinin is produced by activation of the<br />

kinin system. It induces arteriolar dilation and increased<br />

venule permeability through contraction of endothelial cells<br />

and extravascular smooth muscle. Activation of bradykinin<br />

precursors involves activated factor XII (Hageman factor)<br />

generated by its contact with injured tissues. During clotting,<br />

fibrinopeptides produced during the conversion of<br />

fibrinogen to fibrin increase vascular permeability and are<br />

chemotactic for leukocytes. The fibrinolytic system participates<br />

in inflammation through the kinin system. Products<br />

produced during arachidonic acid metabolism also affect<br />

inflammation. These include prostaglandins and leukotrienes<br />

that can mediate essentially every aspect of acute<br />

inflammation.<br />

1<br />

E<br />

3 4<br />

1<br />

CD45 GT<br />

CD19 Positive<br />

CD10 Positive<br />

CD45<br />

Positive<br />

2<br />

CD20<br />

10 3<br />

10 2<br />

10 1<br />

10 0<br />

1 HLA-DR Positive<br />

CD13 Negative<br />

2<br />

HLA-DR<br />

E1 E2<br />

0.0% 1.8%<br />

E3 E4<br />

0.0% 98%<br />

100 101 102 103 1000<br />

CD19 CD34<br />

0.1 1000 0.1<br />

1000<br />

CD2 RD1<br />

CD3 PE-CY5<br />

CD 13 1000<br />

0.1<br />

2<br />

1<br />

CD2 Negative CD3 Negative<br />

CD8 PE 1000<br />

0.1<br />

G G<br />

3<br />

4<br />

3<br />

0.1<br />

Precursor B cell acute lymphoblastic leukemia.<br />

E<br />

4<br />

1000<br />

CD20 Negative<br />

CD34 Positive<br />

2<br />

4<br />

acute lymphoblastic leukemia (ALL)<br />

An undifferentiated and very aggressive type of lymphoid<br />

neoplasm that results from uncontrolled growth of<br />

a progenitor cell that is believed to give rise to both B and<br />

T lymphoid cell lineages. It consists of a heterogeneous<br />

group of lymphopoietic stem cell disorders in which<br />

lymphoblasts accumulate in the bone marrow and suppress<br />

normal hemopoietic cells. Of all ALL cases, 80% are of<br />

the B cell type, whereas the remainder are T cell with rare<br />

cases of null cell origin. Ten percent (10%) of leukemias<br />

are ALL, and 60% of ALL cases occur in children.<br />

Chromosomal abnormalities have been found in most<br />

cases of ALL. B-ALL (L3) is characterized by one of three<br />

chromosomal translocations. Most B-ALL cases involve<br />

A

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!